Bevacizumab/rifampicinLiver dysfunction and haemoptysis: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1562卷 / 1期

关键词：

D O I：

10.1007/s40278-015-3759-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：47 / 47

相关论文

共 50 条

[41] Bevacizumab/erlotinibGastrointestinal perforation and rash: 2 case reports
Reactions Weekly, 2018, 1708 (1) : 80 - 80
[42] Bevacizumab/octreotideDiarrhoea, hypertension and epistaxis: 2 case reports
Reactions Weekly, 2020, 1792 (1) : 54 - 54
[43] Bevacizumab/nivolumabThrombotic microangiopathy and hypertension: 2 case reports
Reactions Weekly, 2023, 1949 (1) : 104 - 104
[44] Bevacizumab/gemcitabine/oxaliplatinVarious toxicities: 2 case reports
Reactions Weekly, 2013, 1450 (1) : 10 - 10
[45] FingolimodLiver dysfunction: 2 case reports
Reactions Weekly, 2018, 1700 (1) : 117 - 117
[46] CitalopramSexual dysfunction: 2 case reports
Reactions Weekly, 2008, 1204 (1) : 12 - 12
[47] CeftazidimeHepatic dysfunction: 2 case reports
Reactions Weekly, 2014, 1494 (1) : 15 - 15
[48] MethotrexateSexual dysfunction: 2 case reports
Reactions Weekly, 2018, 1689 (1) : 130 - 130
[49] LansoprazoleLiver dysfunction: 2 case reports
Reactions Weekly, 2003, 979 (1) : 14 - 14
[50] Aspirin/ticagrelorEpistaxis, haemoptysis and bleeding: 3 case reports
Reactions Weekly, 2020, 1789 (1) : 49 - 49

← 1 2 3 4 5 →